How we helped a mid-size Pharma in the primary immunodeficiency (PID) space to respond successfully to a competitor's move.
The Challenge: Dealing with an existing competitor launching a new product.…
Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!
Over the past few years, corporate venture capital (CVC) companies backed by or…
Gene therapy treatments for Inherited Retinal Disorders (IRD) hold great promise.
Globally 4.5 million people are affected by IRDs — a group of diseases having a…
AAV-based gene therapies: Safe or not? Challenges and considerations for the future.
Adeno-associated virus (AAV) is one of the most studied gene therapy vehicles.…
Decentralized Clinical Trials (DCTs) in Oncology – Is the Pharma Industry ready?
The acceptance of telehealth and the incorporation of digital technologies have…
Metaverse and Healthcare: prepare to enter the Matrix!
No matter how hard it is to believe, we see a concept from a sci-fi movie…
Emerging trends in Hemophilia management. Is it time to say goodbye to standard CFC replacement therapy?
What is hemophilia? Hemophilia is a rare X-linked congenital bleeding disorder.…
Precision medicines: a value-based approach
Precision medicine is a novel and targeted approach for disease treatment and…
Value-based healthcare, a new reality for everyone!
One of the biggest challenges in global healthcare is the rapidly increasing…
NFTs and healthcare, a match made in heaven(?)
What is an NFT? An NFT is a one-of-a-kind digital asset linked to blockchain*…
The sleeping giant of nanomedicine
Nanomedicine applies the tools and knowledge of nanotechnology for the…
A lesser-known competitive strategy involving authorized generics
Authorized generics (AGs) is a less frequently heard terminology but an…